Ole Andreas Halvorsen
Viking Global Investors
Viking Global Investors Portfolio 13F
Ole Andreas Halvorsen Holdings Activity
- Portfolio value:
- $36.37B≈ (+$9B≈)
- Previous value:
- $27.68B≈
- # of changes:
- 102
- New positions:
- 25
- Reported for:
- 31 Dec 2020 (Q4)
- Latest filing date:
- 16 Feb 2021
Viking Global Investors has disclosed a total of 102 changes to the portfolio in the (2020 Q4) SEC report(s): increased the number of shares of 19, bought 25 totally new, decreased the number of shares of 43 and completely sold out 15 position(s).
What stocks did Ole Andreas Halvorsen buy in 2020 Q4?
During 2020 Q4 Ole Andreas Halvorsen has bought 44 securities out of which top 5 purchases (by % change to portfolio) were (MSFT) Microsoft Corp (added shares +43.37%), (FIS) Fidelity National Information Services Inc (added shares +33.18%), (TMUS) T-Mobile US Inc (added shares +7.87%), (GOOGL) Alphabet Inc, CL-A (added shares +222.89%) and (BSX) Boston Scientific Corp (added shares +59.27%).
What did Ole Andreas Halvorsen invest in during 2020 Q4?
In the 2020 Q4 report(s) the following changes have been made to the top investments: (MSFT) Microsoft Corp (added shares +43.37%), (ADPT) Adaptive Biotechnologies Corp (reduced shares -10.45%), (FIS) Fidelity National Information Services Inc (added shares +33.18%) and (TMUS) T-Mobile US Inc (added shares +7.87%).
102 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
UnitedHealth Group Incorporated
|
new
|
$350.68
|
+18.74%($416.40)
|
2.69%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
4D Molecular TherapeuticsInc
|
new
|
$41.45
|
-75.87%($10.00)
|
0.45%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
Abcellera BiologicsInc
|
new
|
$40.24
|
-85.42%($5.86)
|
2.13%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
Acadia Healthcare Company Inc
|
new
|
$50.26
|
-39.59%($30.36)
|
0.05%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
Air Products and Chemicals Inc
|
new
|
$273.22
|
+6.38%($290.64)
|
0.48%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
Arena Pharmaceuticals Inc
|
new
|
$76.83
|
|
0.09%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
Becton Dickinson and Company
|
new
|
$250.22
|
-32.42%($169.10)
|
0.35%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
Bilibili Inc
|
new
|
$85.72
|
-77.37%($19.40)
|
0.31%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
CarMax Inc
|
new
|
$94.46
|
-38.66%($57.94)
|
0.21%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
Walt Disney Company
|
new
|
$181.18
|
-46.18%($97.51)
|
2.13%
|
2020 Q4
|
≈ 0.25 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.